Caffeic acid phenethyl ester protects against oxidative stress and dampens inflammation via heme oxygenase 1
Author
dc.contributor.author
Stähli, Alexandra
Author
dc.contributor.author
Maheen, Ceeneena Ubaidha
Author
dc.contributor.author
Strauss Avendaño, Franz
Author
dc.contributor.author
Eick, Sigrun
Author
dc.contributor.author
Sculean, Anton
Author
dc.contributor.author
Gruber, Reinhard
Admission date
dc.date.accessioned
2019-10-14T15:41:03Z
Available date
dc.date.available
2019-10-14T15:41:03Z
Publication date
dc.date.issued
2019
Cita de ítem
dc.identifier.citation
International Journal of Oral Science, Volumen 11, Issue 1, 2019
Identifier
dc.identifier.issn
20493169
Identifier
dc.identifier.other
10.1038/s41368-018-0039-5
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/171525
Abstract
dc.description.abstract
Periodontal disease is associated with chronic oxidative stress and inflammation. Caffeic acid phenethyl ester (CAPE), which is a
potent inducer of heme oxygenase 1 (HO1), is a central active component of propolis, and the application of propolis improves
periodontal status in diabetic patients. Here, primary murine macrophages were exposed to CAPE. Target gene expression was
assessed by whole-genome microarray, RT-PCR and Western blotting. The antioxidative and anti-inflammatory activities of CAPE
were examined by exposure of the cells to hydrogen peroxide, saliva and periodontal pathogens. The involvement of HO1 was
investigated with the HO1 inhibitor tin protoporphyrin (SnPP) and knockout mice for Nrf2, which is a transcription factor for
detoxifying enzymes. CAPE increased HO1 and other heat shock proteins in murine macrophages. A p38 MAPK inhibitor and Nrf2
knockout attenuated CAPE-induced HO1 expression in macrophages. CAPE exerted strong antioxidative activity. Additionally, CAPE
reduced the inflammatory response to saliva and periodontal pathogens. Blocking HO1 decreased the antioxidative activity and
attenuated the anti-inflammatory activity of CAPE. In conclusion, CAPE exerted its antioxidative effects through the Nrf2-mediated
HO1 pathway and its anti-inflammatory effects through NF-κB inhibition. However, preclinical models evaluating the use of CAPE in
periodontal inflammation are necessary in future studies.